Team Old
Our Team
Team
Glyvantis Bio is a Dublin-based, spin-out from the University College Dublin based on decades of research by Dr. Ioscani Jiménez del Val . Glyvantis Bio is developing Galixa™, a proprietary two-step CHO cell engineering platform that maximizes and stabilizes antibody galactosylation. The company is licensing the Galixa™ technology to industry partners and is developing an internal pipeline of Galixa™ based biologics.
It is backed by a highly experienced and globally recognized team.
CSO
SCIENTIFIC FOUNDER
Dr. Ioscani Jiménez del Val
CEO
CO-FOUNDER
Gertjan Bartlema
CBO
CO-FOUNDER
Peter Greaney
CMO
CO-FOUNDER
Kevin Lynch, MB BS
CHAIRMAN
CO-FOUNDER
John Browne
COUNSEL
CO-FOUNDER
Peter Cicala
Scientific Advisory Board
Prof. Dr. Gestur Vidarsson (Chair)
PI and head of Immunoglobulin Research at Sanquin Research at the Utrecht University
Prof. Ellen van der Schoot
Emeritus prof. Experimental Immunohematology, Chair of WIRhE
Patrick van Berkel
Former Senior Vice President R&D ADC Therapeutics
Mark O'Mahony
Former Chief Manufacturing Officer Leap Therapeutics